» Articles » PMID: 36284400

Extracellular Matrix Remodeling Biomarkers in Coronary Artery Disease

Abstract

Atherosclerosis and one of its most serious consequences, coronary artery disease, are important sources of morbidity and mortality globally, necessitating early detection and treatment. Considering their complex pathophysiology, including several harmful processes, a comprehensive approach to diagnosis, prognosis, and therapy is very desirable. Extracellular matrix remodeling is a major component of this dangerous cascade, including the cleavage of constituents (collagen, elastin, proteoglycans) and the propagation or exacerbation of the inflammatory response. Several extracellular matrix degradation indicators have been hypothesized to correlate with the existence, severity, and prognosis of coronary artery disease. The potency of matrix metalloproteinases, notably collagenases and gelatinases, has been the most thoroughly investigated in clinical studies. Stromelysins, matrilysins, transmembrane matrix metalloproteinases, collagen and laminin turnover indicators, as well as fibronectin, have also been studied to a lesser level. Among the most well-studied markers, MMP-1, MMP-2, MMP-8, and MMP-9 have been found increased in patients with cardiovascular risk factors such as metabolic syndrome, its components (obesity, dyslipidemia, diabetes mellitus), and smoking. Increasing concentrations are detected in acute coronary syndromes compared to stable angina pectoris and healthy control groups. It should also be stressed that those extracellular matrix biomarkers may also be detected in high concentrations in other vascular pathologies such as peripheral artery disease, carotid artery disease, aortic aneurysms, and dissections. Despite the advances gained, future research should focus on their importance and, more crucially, their added utility as biomarkers in identifying persons at risk of developing overt coronary artery disease. At the same time, determining the prognosis of coronary artery disease patients using such biomarkers may be important for their adequate care.

Citing Articles

Association between Inflammation and New-Onset Atrial Fibrillation in Acute Coronary Syndromes.

Baghina R, Crisan S, Luca S, Patru O, Lazar M, Vacarescu C J Clin Med. 2024; 13(17).

PMID: 39274304 PMC: 11396258. DOI: 10.3390/jcm13175088.


Coronary Plaque Erosion: Epidemiology, Diagnosis, and Treatment.

Theofilis P, Vlachakis P, Papanikolaou A, Karakasis P, Oikonomou E, Tsioufis K Int J Mol Sci. 2024; 25(11).

PMID: 38891972 PMC: 11171599. DOI: 10.3390/ijms25115786.


Evaluation of MMP-9, IL-6, TNF-α levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease.

Akbari T, Kazemi Fard T, Fadaei R, Rostami R, Moradi N, Movahedi M J Cardiovasc Thorac Res. 2024; 15(4):223-230.

PMID: 38357561 PMC: 10862034. DOI: 10.34172/jcvtr.2023.31844.


The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations.

Theofilis P, Oikonomou E, Tsioufis K, Tousoulis D Int J Mol Sci. 2023; 24(11).

PMID: 37298518 PMC: 10253295. DOI: 10.3390/ijms24119568.


Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target.

Sagris M, Theofilis P, Antonopoulos A, Tsioufis K, Tousoulis D Int J Mol Sci. 2022; 23(24).

PMID: 36555658 PMC: 9781338. DOI: 10.3390/ijms232416010.

References
1.
Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

2.
Dai H, Much A, Maor E, Asher E, Younis A, Xu Y . Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes. 2020; 8(1):50-60. PMC: 8728029. DOI: 10.1093/ehjqcco/qcaa076. View

3.
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C . 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019; 41(3):407-477. DOI: 10.1093/eurheartj/ehz425. View

4.
Chistiakov D, Sobenin I, Orekhov A . Vascular extracellular matrix in atherosclerosis. Cardiol Rev. 2013; 21(6):270-88. DOI: 10.1097/CRD.0b013e31828c5ced. View

5.
Steinberg D, Witztum J . Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010; 30(12):2311-6. DOI: 10.1161/ATVBAHA.108.179697. View